TherapeuticsMD, Inc.
TXMD
$2.55
$0.062.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.80M | 2.56M | 1.84M | 1.76M | 1.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.80M | 2.56M | 1.84M | 1.76M | 1.60M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 2.80M | 2.56M | 1.84M | 1.76M | 1.60M |
| SG&A Expenses | 4.12M | 4.45M | 4.50M | 4.74M | 5.34M |
| Depreciation & Amortization | 387.00K | 387.00K | 471.00K | 509.00K | 1.05M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.51M | 4.83M | 4.97M | 5.25M | 6.39M |
| Operating Income | -1.71M | -2.27M | -3.13M | -3.49M | -4.79M |
| Income Before Tax | 10.00K | -607.00K | -2.20M | -2.34M | -4.01M |
| Income Tax Expenses | -63.00K | -63.00K | -63.00K | -31.00K | -43.00K |
| Earnings from Continuing Operations | 0.07 | -0.54 | -2.14 | -2.31 | -3.97 |
| Earnings from Discontinued Operations | 229.00K | 85.00K | 39.00K | 131.00K | 651.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 302.00K | -459.00K | -2.10M | -2.18M | -3.32M |
| EBIT | -1.71M | -2.27M | -3.13M | -3.49M | -4.79M |
| EBITDA | -1.32M | -1.89M | -2.66M | -2.98M | -4.23M |
| EPS Basic | 0.03 | -0.04 | -0.18 | -0.19 | -0.29 |
| Normalized Basic EPS | -0.06 | -0.10 | -0.11 | -0.13 | -0.15 |
| EPS Diluted | 0.02 | -0.05 | -0.19 | -0.19 | -0.30 |
| Normalized Diluted EPS | -0.06 | -0.10 | -0.11 | -0.13 | -0.15 |
| Average Basic Shares Outstanding | 46.23M | 46.19M | 46.15M | 46.13M | 45.64M |
| Average Diluted Shares Outstanding | 46.23M | 46.19M | 46.15M | 46.13M | 45.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |